Mirum Pharmaceuticals (MIRM) Assets (2018 - 2026)

Mirum Pharmaceuticals' Assets history runs 9 years deep, the most recent figure standing at $890.9 million for Q1 2026.

• On a quarterly basis, Assets rose 29.07% year-over-year to $890.9 million in Q1 2026; TTM through Mar 2026 was $890.9 million, a 29.07% increase from a year earlier, with the FY2025 full-year figure at $842.8 million, up 25.65% from the prior year.
• Assets grew to $890.9 million in Q1 2026 per MIRM's latest filing, from $842.8 million in the prior quarter.
• Across five years, Assets topped out at $890.9 million in Q1 2026 and bottomed at $278.1 million in Q1 2022.
• The 5-year median for Assets is $652.0 million (2024), against an average of $585.5 million.
• Biggest YoY gain for Assets was 95.47% in 2024; the steepest drop was 2.65% in 2024.
• Year by year, Assets stood at $352.9 million in 2022, then soared by 83.23% to $646.6 million in 2023, then advanced by 3.73% to $670.8 million in 2024, then increased by 25.65% to $842.8 million in 2025, then advanced by 5.71% to $890.9 million in 2026.
• Per Business Quant, the three latest MIRM Assets figures stand at $890.9 million (Q1 2026), $842.8 million (Q4 2025), and $785.1 million (Q3 2025).